Physician profile
Deepak Seth
NPI 1154396711
$15,909.40
in general payments reported to CMS, 2019-2025
57 companies · $3,344 in 2025
The $3,344 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,146 · 2020: $2,507 · 2021: $2,025 · 2022: $2,416 · 2023: $1,467 · 2024: $2,005 · 2025: $3,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,815.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,423.47 | 2019-2025 | Breztri, Tezspire, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,306.54 | 2019-2025 | Xifaxan, Trulance |
| Novo Nordisk INC | $1,136.31 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $1,120.91 | 2019-2025 | |
| Abbvie INC. | $962.94 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Lilly USA, LLC | $898.08 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $718.09 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Vanda Pharmaceuticals INC. | $593.67 | 2019-2025 | Fanapt, Hetlioz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $556.14 | 2019-2025 | Jardiance, Ofev, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $518.66 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $489.82 | 2019-2022 | |
| Amgen INC. | $468.89 | 2020-2025 | Repatha, Otezla, Repatha |
| Orexo US, INC. | $454.41 | 2020-2025 | Zubsolv |
| Gilead Sciences, INC. | $454.16 | 2022-2025 | |
| Phathom Pharmaceuticals, INC. | $453.49 | 2024-2025 | Voquezna |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Seth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.